Search research articles
Contact Us
Filters
Showing results (11-20 of 60) with videos related to
Page
of 6
Sort By:
Bioorganic & Medicinal Chemistry
|
May 1, 2009
New antituberculotics originated from salicylanilides with promising in vitro activity against atypical mycobacterial strains
Ales Imramovský, Jarmila Vinsová, Juana Monreal Férriz, et al.
International Journal of Molecular Sciences
|
August 21, 2013
Oximes: inhibitors of human recombinant acetylcholinesterase. A structure-activity relationship (SAR) study
Vendula Sepsova, Jana Zdarova Karasova, Jan Korabecny, et al.
Archiv Der Pharmazie
|
January 13, 2009
N-benzylsalicylthioamides: highly active potential antituberculotics
Rafael Dolezal, Karel Waisser, Eva Petrlíková, et al.
Archives of Toxicology
|
September 2, 2016
SAR study to find optimal cholinesterase reactivator against organophosphorous nerve agents and pesticides
Lukas Gorecki, Jan Korabecny, Kamil Musilek, et al.
Neurotoxicity Research
|
October 9, 2016
Concentration of Donepezil in the Cerebrospinal Fluid of AD Patients: Evaluation of Dosage Sufficiency in Standard Treatment Strategy
Martin Valis, Jiri Masopust, Oldrich Vysata, et al.
European Journal of Medicinal Chemistry
|
February 7, 2018
Rational design of novel TLR4 ligands by in silico screening and their functional and structural characterization in vitro
Jan Honegr, David Malinak, Rafael Dolezal, et al.
Expert Opinion on Therapeutic Patents
|
June 2, 2017
Progress in acetylcholinesterase reactivators and in the treatment of organophosphorus intoxication: a patent review (2006-2016)
Lukas Gorecki, Jan Korabecny, Kamil Musilek, et al.
Toxins
|
September 28, 2018
Molecular Modeling Studies on the Interactions of Aflatoxin B1 and Its Metabolites with Human Acetylcholinesterase. Part II: Interactions with the Catalytic Anionic Site (CAS)
Joyce S F D de Almeida, Rafael Dolezal, Ondrej Krejcar, et al.
Bioorganic Chemistry
|
September 6, 2020
From orexin receptor agonist YNT-185 to novel antagonists with drug-like properties for the treatment of insomnia
Eva Mezeiova, Jana Janockova, Jan Konecny, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 3, 2014
6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity
David Malinak, Rafael Dolezal, Jan Marek, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 60) with videos related to
Sort By:
Page
of 6
Bioorganic & Medicinal Chemistry
|
May 1, 2009
New antituberculotics originated from salicylanilides with promising in vitro activity against atypical mycobacterial strains
Ales Imramovský, Jarmila Vinsová, Juana Monreal Férriz, et al.
International Journal of Molecular Sciences
|
August 21, 2013
Oximes: inhibitors of human recombinant acetylcholinesterase. A structure-activity relationship (SAR) study
Vendula Sepsova, Jana Zdarova Karasova, Jan Korabecny, et al.
Archiv Der Pharmazie
|
January 13, 2009
N-benzylsalicylthioamides: highly active potential antituberculotics
Rafael Dolezal, Karel Waisser, Eva Petrlíková, et al.
Archives of Toxicology
|
September 2, 2016
SAR study to find optimal cholinesterase reactivator against organophosphorous nerve agents and pesticides
Lukas Gorecki, Jan Korabecny, Kamil Musilek, et al.
Neurotoxicity Research
|
October 9, 2016
Concentration of Donepezil in the Cerebrospinal Fluid of AD Patients: Evaluation of Dosage Sufficiency in Standard Treatment Strategy
Martin Valis, Jiri Masopust, Oldrich Vysata, et al.
European Journal of Medicinal Chemistry
|
February 7, 2018
Rational design of novel TLR4 ligands by in silico screening and their functional and structural characterization in vitro
Jan Honegr, David Malinak, Rafael Dolezal, et al.
Expert Opinion on Therapeutic Patents
|
June 2, 2017
Progress in acetylcholinesterase reactivators and in the treatment of organophosphorus intoxication: a patent review (2006-2016)
Lukas Gorecki, Jan Korabecny, Kamil Musilek, et al.
Toxins
|
September 28, 2018
Molecular Modeling Studies on the Interactions of Aflatoxin B1 and Its Metabolites with Human Acetylcholinesterase. Part II: Interactions with the Catalytic Anionic Site (CAS)
Joyce S F D de Almeida, Rafael Dolezal, Ondrej Krejcar, et al.
Bioorganic Chemistry
|
September 6, 2020
From orexin receptor agonist YNT-185 to novel antagonists with drug-like properties for the treatment of insomnia
Eva Mezeiova, Jana Janockova, Jan Konecny, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 3, 2014
6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity
David Malinak, Rafael Dolezal, Jan Marek, et al.
Page
of 6